This article was originally published on The limbic Subcutaneous daratumumab with pomalidomide and dexamethasone (D-Pd) is an effective and...
Burden of Disease
New Zealand falling behind rest of world in cancer treatment, according to new myeloma report
Originally published on Health Industry Hub The management of New Zealand’s most common blood cancer, myeloma, is falling behind the rest of the...
New Zealand lacks treatment access to myeloma patients – Myeloma New Zealand
This story was originally published on RNZ An advocate group is warning that New Zealanders are dying from a common blood cancer because they've...
NZ falling behind rest of world in cancer treatment – Myeloma NZ
The management of New Zealand’s most common blood cancer, myeloma, is falling behind the rest of the world, putting lives at unnecessary risk of...
New Zealand lacking best treatment options for blood cancer patients, warns Myeloma NZ
This story was originally published on the NZ Herald Kiwis diagnosed with the country's most common form of blood cancer are being put at...